Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

EBAP

Financiado

Cerrado

Evidence Based Assessment in Psychotherapy EBAP Study

Mood disorders (MDs) affect more than 300 million people. They are the third leading causes in 2017 of years lived with disability. Currently, pharmacotherapy represents the first-line option, but growing evidence suggests that al... ver más

07/10/2024

UNIPV

264K€

Presupuesto del proyecto: 264K€

Líder del proyecto

UNIVERSITA DEGLI STUDI DI PAVIA No se ha especificado una descripción o un objeto social para esta compañía.

Fecha límite participación Sin fecha límite de participación.

Ver 4 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2024-10-07

MSCA-IF-2020: Individual Fellowships Objective:The goal of the Individual Fellowships is to enhance the creative and innovative potential...

I+D

Cerrada hace 4 años

0% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

4 Participantes

UNIPV

263.73K€ | Lider

THE UNIVERSITY OF NORTH CARO...

FUNDACIO CLINIC PER A LA REC...

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 41 meses Fecha Inicio: 2021-04-15
Fecha Fin: 2024-10-07

Líder del proyecto

UNIVERSITA DEGLI STUDI DI PAVIA No se ha especificado una descripción o un objeto social para esta compañía.

Presupuesto del proyecto 264K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Mood disorders (MDs) affect more than 300 million people. They are the third leading causes in 2017 of years lived with disability. Currently, pharmacotherapy represents the first-line option, but growing evidence suggests that although it is effective in the treatment of acute episodes, medication alone does not help many patients to achieve a functional recovery. However, despite it being established that psychotherapies are effective in treating MDs, there is still much to improve in our understanding, management, and treatment of MDs. Waiting for progress in personalized psychiatric treatment approaches that could lead to precise biological and psychosocial interventions, the treatment of MDs remained, to a large extent, subjective clinical exercise. Implementing evidence-based assessment (EBA) and treatment for MD is essential to reduce their burden at an individual, societal and public health levels. An efficient assessment process is essential because it leads to more accurate diagnosis, better treatment matching, increased patient engagement, and enhanced outcomes. When deciding how to conduct such EBA, the clinician has to consider the target content for the assessment, the function that the assessment could serve in the treatment context, and the different candidate assessments available. This project has three main goals: (1) to develop and evaluate (pilot study) an EBA approach to individual psychotherapy that is valid and easy enough to be administered routinely in real-world psychotherapeutic settings; (2) to roll out the EBA approach in real-world psychotherapeutic settings to investigate (randomised controlled clinical trial) how it affects psychotherapy process and outcome; (3) to disseminate/notify the project study results to both academic and clinical communities. By combining sophisticated models of therapeutic process (Contextual and Quadripartite Models) with EBA, we expect to show increases in rapport, fewer ruptures and premature treatment

Conecta tu I+D

Entra hoy

¿Olvidó su contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores